Literature DB >> 10817508

Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7.

M C Kamradt1, N Mohideen, E Krueger, S Walter, A T Vaughan.   

Abstract

Through a glucocorticoid-responsive promoter, glucocorticoids can regulate the transcription of the human papillomavirus (HPV) E6 and E7 viral genes which target the tumour suppressor proteins p53 and Rb respectively. In C4-1 cells, the glucocorticoid dexamethasone up-regulated HPV E6/E7 mRNA and decreased radiation-induced apoptosis. In contrast, dexamethasone had no effect on apoptosis of cells that either lack the HPV genome (C33-a) or in which HPV E6/E7 transcription is repressed by dexamethasone (SW756). Irradiated C4-1 cells showed increased p53 expression, while dexamethasone treatment prior to irradiation decreased p53 protein expression. In addition, p21 mRNA was regulated by irradiation and dexamethasone in accordance with the observed changes in p53. Overall, glucocorticoids decreased radiation-induced apoptosis in cervical carcinoma cells which exhibit increased HPV E6/E7 transcription and decreased p53 expression. Therefore, in HPV-infected cervical epithelial cells, p53-dependent apoptosis appears to depend upon the levels of HPV E6/E7 mRNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817508      PMCID: PMC2374500          DOI: 10.1054/bjoc.2000.1114

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

1.  p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines.

Authors:  Y Yu; J B Little
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

2.  Steroid contraceptive use and cervical dysplasia: increased risk of progression.

Authors:  E Stern; A B Forsythe; L Youkeles; C F Coffelt
Journal:  Science       Date:  1977-06-24       Impact factor: 47.728

3.  Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.

Authors:  A Kangas; D W Nicholson; E Hölttä
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.

Authors:  K Butz; C Geisen; A Ullmann; D Spitkovsky; F Hoppe-Seyler
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

6.  Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

Authors:  T D Kessis; R J Slebos; W G Nelson; M B Kastan; B S Plunkett; S M Han; A T Lorincz; L Hedrick; K R Cho
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.

Authors:  M Iglesias; K Yen; D Gaiotti; A Hildesheim; M H Stoler; C D Woodworth
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

8.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.

Authors:  B Gloss; H U Bernard; K Seedorf; G Klock
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  5 in total

Review 1.  Nervous system regulation of the cancer genome.

Authors:  Steven W Cole
Journal:  Brain Behav Immun       Date:  2012-12-01       Impact factor: 7.217

2.  High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.

Authors:  Martin Dreilich; Michael Bergqvist; Martin Moberg; Daniel Brattström; Inger Gustavsson; Stefan Bergström; Alkwin Wanders; Patrik Hesselius; Gunnar Wagenius; Ulf Gyllensten
Journal:  BMC Cancer       Date:  2006-04-18       Impact factor: 4.430

Review 3.  Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.

Authors:  Nora Sundahl; Dorien Clarisse; Marc Bracke; Fritz Offner; Wim Vanden Berghe; Ilse M Beck
Journal:  Oncoscience       Date:  2016-07-27

Review 4.  The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.

Authors:  Janice García-Quiroz; Bismarck Vázquez-Almazán; Rocío García-Becerra; Lorenza Díaz; Euclides Avila
Journal:  Cells       Date:  2022-08-15       Impact factor: 7.666

Review 5.  Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers.

Authors:  V Bol; V Grégoire
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.